Connect your AI

Boston Scientific BSX Total Current Assets

Total Current Assets at other companies

AbbottABT

$24.52B+0.2%

TFX

TeleflexTFX

$1.86B+20.8%

Johnson & JohnsonJNJ

$59.77B+9.7%

StrykerSYK

$14.42B+10.9%

HaemoneticsHAE

$834.88M-10.7%

CONMEDCNMD

$675.67M+2.7%

Other financials

Income statement

Revenue$5.4B+7.5%

Gross profit$3.8B+12.4%

Operating income$1.2B+43.8%

Net income$907.0M+14.1%

EPS (diluted)$0.61+15.1%

Balance sheet

Cash & equivalents$850.0M+146%

Total debt$659.0M-94.1%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.3%

Free cash flow$171.0M-51.7%

Valuation

Market cap$68.43B-56.7%

P/E18.6×-44.6×

P/S3.3×-5.3×

Profitability

Gross margin69.9%+1.7pp

Operating margin19.8%+2.8pp

Net margin17.5%+4.0pp

FCF margin16.9%-0.3pp

Returns & leverage

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Boston Scientific's total current assets?: Boston Scientific (BSX) reported total current assets of $8.68B in Q1 2026.
How has Boston Scientific's total current assets changed year-over-year?: Boston Scientific's total current assets increased by 18.4% year-over-year, from $7.34B to $8.68B.
What is the long-term trend for Boston Scientific's total current assets?: Over 5 years (2020 to 2025), Boston Scientific's total current assets has grown at a 5.6% compound annual growth rate (CAGR), from $6.69B to $8.79B.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.